Post-Doctoral Scientist, Immunology at Eli Lilly and Company

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

PhD in Immunology or Cellular Biology completed by October/November 2025
Strong background in the study of immune cells
Strong experience in cellular immunology, flow cytometry, and mouse in vivo models (experience working with Tregs a plus)
Exceptional communicator (oral and written) with a strong publication record
Proficient in data analysis and reporting (PRISM, Excel, Powerpoint, FlowJo)
Self-directed and highly motivated scientist who wants to learn new techniques while pursuing research and publication goals

Responsibilities

Study Treg function in tissues at different stages of autoimmune diseases
Design and execute experiments to test hypotheses related to disease mechanisms
Conduct literature searches and review relevant scientific literature to inform research strategy and identify emerging trends in the field of Tregs
Develop and deliver effective communications for technical and non-technical audiences; prepare and present scientific reports and publications
Collaborate effectively with colleagues at all levels to advance project goals
Apply advanced scientific knowledge to develop creative solutions to complex problems
Plan and schedule work independently, prioritize tasks, and manage time effectively

Skills

Immunology

Cellular Biology

Tregs

Autoimmune Diseases

Immune Cells

Experimental Design

Literature Review

Scientific Communication

Project Planning

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free